Specifically, DPP4 inhibitors have been shown to mitigate endoplasmic reticulum stress, which often occurs in the beta cells of patients with diabetes, while also aiding in insulin production to compensate for this stress.25 This evidence concerns the gene DPP4 and diabetes mellitus.